Search by Drug Name or NDC
NDC 00904-7252-61 Sennosides 8.6 mg/1 Details
Sennosides 8.6 mg/1
Sennosides is a ORAL TABLET, FILM COATED in the HUMAN OTC DRUG category. It is labeled and distributed by Major Pharmaceuticals. The primary component is SENNOSIDES.
MedlinePlus Drug Summary
Senna is used on a short-term basis to treat constipation. It also is used to empty the bowels before surgery and certain medical procedures. Senna is in a class of medications called stimulant laxatives. It works by increasing activity of the intestines to cause a bowel movement.
Related Packages: 00904-7252-61Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Senna
Product Information
| NDC | 00904-7252 |
|---|---|
| Product ID | 0904-7252_df3b431b-a1ae-91dd-e053-2995a90aa02f |
| Associated GPIs | |
| GCN Sequence Number | 019964 |
| GCN Sequence Number Description | sennosides TABLET 8.6 MG ORAL |
| HIC3 | D6S |
| HIC3 Description | LAXATIVES AND CATHARTICS |
| GCN | 00701 |
| HICL Sequence Number | 001289 |
| HICL Sequence Number Description | SENNOSIDES |
| Brand/Generic | Generic |
| Proprietary Name | Sennosides |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Sennosides |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 8.6 |
| Active Ingredient Units | mg/1 |
| Substance Name | SENNOSIDES |
| Labeler Name | Major Pharmaceuticals |
| Pharmaceutical Class | n/a |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Listing Certified Through | 2024-12-31 |
Package
Package Images
NDC 00904-7252-61 (00904725261)
| NDC Package Code | 0904-7252-61 |
|---|---|
| Billing NDC | 00904725261 |
| Package | 10 BLISTER PACK in 1 BOX, UNIT-DOSE (0904-7252-61) / 10 TABLET, FILM COATED in 1 BLISTER PACK |
| Marketing Start Date | 2022-05-17 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.02383 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | SENNA-LAX 8.6 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | Y |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis
Standard Product Labeling (SPL)/Prescribing Information SPL df3b431b-a1ad-91dd-e053-2995a90aa02f Details
Uses
SPL UNCLASSIFIED SECTION
Ask a doctor before use if you have
stomach pain
nausea
vomiting
noticed a sudden change in bowel habits that continues over a period of 2 weeks
Directions
take preferably at bedtime or as directed by a doctor
| age | starting dosage | maximum dosage |
| adults and children 12
years of age and over | 2 tablets once
a day | 4 tablets twice
a day |
| children 6 to under
12 years | 1 tablet once
a day | 2 tablets twice
a day |
| children 2 to under
6 years | 1/2 tablet once
a day | 1 tablet twice
a day |
| children under
2 years | ask a doctor | ask a doctor |
Other information
SPL UNCLASSIFIED SECTION
SPL UNCLASSIFIED SECTION
PRINCIPAL DISPLAY PANEL
INGREDIENTS AND APPEARANCE
| SENNOSIDES
sennosides tablet, film coated |
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||
| Labeler - Major Pharmaceuticals (191427277) |
Revised: 5/2022
Document Id: df3b431b-a1ae-91dd-e053-2995a90aa02f
Set id: df3b431b-a1ad-91dd-e053-2995a90aa02f
Version: 1
Effective Time: 20220517